×
Eli Lilly Inventory 2010-2024 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for the quarter ending December 31, 2024 was
$7.589B
, a
31.46% increase
year-over-year.
Eli Lilly inventory for 2024 was
$7.589B
, a
31.46% increase
from 2023.
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
Eli Lilly inventory for 2022 was
$4.31B
, a
10.9% increase
from 2021.
View More
Eli Lilly Inventory 2010-2024 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for 2024 was
$7.589B
, a
31.46% increase
from 2023.
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
Eli Lilly inventory for 2022 was
$4.31B
, a
10.9% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Johnson & Johnson (JNJ)
$384.4B
Novo Nordisk (NVO)
$375.8B
AbbVie (ABBV)
$354.6B
Roche Holding AG (RHHBY)
$262.5B
Merck (MRK)
$221.8B
Novartis AG (NVS)
$219.3B
Pfizer (PFE)
$146.8B
Sanofi (SNY)
$137.4B
Bayer (BAYRY)
$22.6B
Innoviva (INVA)
$1.1B